Emily Hayes - September 6, 2024 Preparing your patent for success in EPO opposition proceedings Emily Hayes shares five simple prosecution tips to strengthen EP patents, ensuring they are in the ...
Maria Hall - September 5, 2024 Mewburn Ellis has donated over £1,000,000 to charity Today marks International Day of Charity (September 5th), since 2020, we have donated over ...
Maria Hall - September 4, 2024 Mewburn Ellis recognised as one of the UK’s Best Workplaces in Consulting and Professional Services! We are proud to announce that following on from our recent announcement of being officially named ...
Alex Galbraith - September 4, 2024 We perform significantly better than the EPO average at oppositions We really are experts when it comes to opposing patents and our enviable success rate speaks for ...
Maria Hall - September 3, 2024 Mewburn Ellis donate £10,000, to All About Trans Once again, our LGBTQ+ group has chosen All About Trans as one of their charities to support this ...
Andrew Fearnside - September 2, 2024 Phasecraft: the pioneer in quantum software The Bristol and London company, which has recently opened an office in Washington DC, is a world ...
Lucy Coe - September 2, 2024 UPC Weekly - Let’s brake for a minute, and talk about Tesla 2024 Week 35 Last week saw two decisions handed down from the UPC Local Divisions as part of ...
Maria Hall - August 28, 2024 Mewburn Ellis donate £20,000 to Jonathan's Voice As part of our community programme our inclusion and diversity collaboration group have once again ...
Emma Kennaugh-Gallacher - August 27, 2024 UPC Preliminary Injunctions – Background, Trends and Lessons Learned 2024 Week 34 No-one wants to be on the receiving end of a UPC preliminary injunction. The tussles ...
Sarah Harvey - August 23, 2024 The Science of Success: Optimising Female Athletic Performance For the first time in Olympic history, the Paris 2024 Games achieved gender parity among athletes. ...
Alice Jefferies - August 21, 2024 Editing in situ: synthetic gene editing tools delivered straight to the gut The critical, yet delicate balance of the microbiome in maintaining health and influencing disease ...
Robert Andrews - August 20, 2024 Antibody-drug conjugates: the new frontier of cancer treatments Antibody-drug conjugates (ADCs) are big business. Big pharma is moving in, snapping up companies or ...
Maria Hall - August 19, 2024 Mewburn Ellis donate £7,500 to Mothers for Mothers Our WoMEn network here at Mewburn are passionate about giving back and supporting the community, ...
Matthew Naylor - August 19, 2024 UPC Weekly - Revisiting transparency of UPC proceedings 2024 Week 33 The UPC has been doing a lot of stuff right. Litigators praise the preparedness of the ...
Emily Sullivan - August 14, 2024 Cipla Europe NV v Glaxo Group Ltd: can a 3D trade mark be distinctive? Trade mark proceedings can often feel like never-ending stories. In this case, Glaxo Group Ltd. ...
Emma Graham - August 14, 2024 King’s Speech: AI implications for IP Featuring in The Patent Lawyer Magazine, Emma Graham explores what the King's Speech said about AI, ...
Nick Sutcliffe - August 13, 2024 Cellular agriculture – increasing importance of IP in cultivated meat As the cultivated meat industry matures, consolidation is widely anticipated due to increasing ...
Sean Jauss - August 12, 2024 UPC Weekly - Now let’s talk about saisies 2024 Week 32 There is no discovery at the UPC.
Maria Hall - August 9, 2024 Mewburn Ellis Donate £7,500 to Forgotten Women This year the WoMen network here at Mewburn are supporting ‘Forgotten Women’ a charity run by women ...
Louise Atkins - August 9, 2024 Fin-tastic innovation: diving into the future of lab-grown fish Much of the discussion around future food focusses on cultivated meat, with all the products so-far ...
Eleanor Maciver - August 7, 2024 Mewburn Ellis Donate £5,000 to Action for Conservation As part of our community giving project, we’re proud to support Action for Conservation (AFC), a UK ...
Lauren Woolley - August 6, 2024 Cell-to-cup: a new way to make an old favourite? For those of us who can’t function without our morning coffee, there have been some promising ...
Matthew Naylor - August 5, 2024 UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo 2024 Week 31 What happens when you have the same parties fighting over revocation of the same ...
Joe Egelstaff - August 1, 2024 Navigating the Dual Pathways: Regulatory Approval and Patent Protection for Medical Devices For medical device manufacturers and designers, the journey to market success hinges on two crucial ...
Richard Clegg - July 31, 2024 New EU sanctions against Russia In late June the EU extended their package of sanctions in view of Russia’s actions in Ukraine by ...
Matthew Naylor - July 29, 2024 UPC Weekly - Where’s your UPC off-ramp? 2024 Week 30 Every litigator needs to have a clear view of the possible routes out of litigation. ...
Jeremy Webster - July 26, 2024 Meet the team: Jeremy Webster, Partner, Head of Chemistry As part of our 'meet the team' series, we talk to partner and head of chemistry, Jeremy Webster, ...
Thomas Wolter - July 22, 2024 UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step 2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent ...
Alex Burns - July 19, 2024 An emotional day - The Court of Appeal reverses the High Court’s earlier judgment Today, the Court of Appeal handed down its hotly-anticipated judgment in the Emotional Perception ...
Lesley Gardner - July 18, 2024 National Paralegal Awards Finalists 2024 We are extremely proud to announce our finalists in the National Paralegal Awards 2024 which ...
Louise Atkins - July 17, 2024 Paw-some news for pets: UK’s first regulatory approval of cultivated meat Lab-grown chicken from cultivated meat company Meatly has received regulatory approval in the UK.
Adam Gregory - July 15, 2024 Mewburn Ellis is proud to have worked on 26 of the 100 top-selling pharmaceuticals of 2023 Mewburn Ellis is proud to work with some of the world’s most globally significant pharmaceuticals, ...
Matthew Naylor - July 15, 2024 UPC Weekly - UPC Local Divisions - the reluctant bifurcators 2024 Week 28 This week we look at how the UPC is handling requests to split substantive ...
Matthew Naylor - July 8, 2024 UPC Weekly - UPC overturns EPO opposition division decision on the same prior art 2024 Week 27 In the race to be the first UPC division to produce a written decision on a main ...
Joshua Tall - July 5, 2024 Quantum Technology in Denmark Mewburn Ellis is excited to announce that we now have a part-time office at The BioInnovation ...
Eliot Ward - July 3, 2024 Inside the Asian microbiome library AMILI co-founder Dr Jeremy Lim takes us on a tour of his remarkable lab, where the mysteries of the ...
Matthew Naylor - July 1, 2024 UPC Weekly - Three month delay fatal for a preliminary injunction application 2024 Week 26 On 3 June 2024, the UPC Local Division in Hamburg decided to refuse a preliminary ...
Emma Kennaugh-Gallacher - June 28, 2024 Living with artificial intelligence: can the law cope? As part of our Thought Leaders series, we explore the copyright issues arising from AI-generated ...
Joanna Smith - June 28, 2024 More recognition in MIP IP Stars 2024 It is fantastic to once again be recognised in MIP IP Stars 2024. So far this year, we have ...
Claire Evans - June 26, 2024 Update on Trade Mark Protection in Jersey, Guernsey, Gibraltar and the Isle of Man Some countries allow trade mark owners to extend their UK and EU trade mark protection into other ...
Callum McGuinn - June 25, 2024 Battery Patents: Clearing the Way Speaking to Intercalation, Callum McGuinn explores what has been happening in battery patent ...
Jane Liu - June 25, 2024 Alive with Possibilities - The Future of Sustainable Plastics and Beyond As the production and consumption of plastics continues to surge, so too has the accumulation of ...
Joseph Newcombe - June 24, 2024 FDA decision on MDMA therapy hangs in the balance Recent positive data from a phase III clinical trial of MDMA assisted psychotherapy for the ...
Matthew Naylor - June 24, 2024 UPC Weekly - UPC uses EPO approach to added subject matter 2024 Week 25 There was lots of UPC news to hold the interest this week but for me the standout was ...
Matthew Naylor - June 17, 2024 UPC Weekly - Opting-out from the UPC: the Who, the When and the Why 2024 Week 24 It seems like a long time ago now, but from March to May 2023, the “sunrise period” of ...
Adam Gregory - June 17, 2024 Podcast with Adam Gregory: protecting innovations in the biotech space Adam Gregory joins John Joson Ng on Nucleate Singapore’s Pulse podcast where he highlights success ...
Eliot Ward - June 14, 2024 How helpful are biological deposits at the EPO? In our article about biological deposits under the Budapest Treaty, we explored the deadlines and ...
Matthew Naylor - June 10, 2024 UPC Weekly - Three Known Unknowns at the UPC 2024 Week 23 It’s a bit risky to write a blog where you hope it will go out of date quickly. But ...
Callum McGuinn - June 6, 2024 How liquid air can store solar and wind energy Storing energy from solar and wind is a huge challenge. We talk to Highview Power, whose liquid air ...
Maria Hall - June 6, 2024 Mewburn Ellis is first European IP firm to earn Great Place To Work Certification™ We are proud to have been officially named as a Great Place To Work™ 2024 by Great Place To Work®, ...
Eliot Ward - June 5, 2024 Unitary patent and UPC to cover Romania from 1 September 2024 The first enlargement of the UPC and Unitary Patent (UP) territory will happen on 1 September 2024, ...
Alice Jefferies - June 4, 2024 The HPV vaccine: the global success of prioritising women’s health Let's talk about the HPV vaccine - a revolutionary drug and global strategy that proved how ...
Sean Jauss - June 3, 2024 1st Anniversary of the UPC – some stats! The Unified Patent Court (UPC) celebrated its first anniversary on 1 June 2024. The Court is busy. ...
Matthew Naylor - June 3, 2024 UPC Weekly - Should we stay or should we go on? 2024 Week 22 This week we report on the UPC revocation action in Bitzer v. Carrier and the related ...
Camille Terfve - May 31, 2024 How data changed our understanding and care of breast cancer Breast cancer does not only affect women, but it mostly affects them1. Breast cancer is the most ...
Matthew Naylor - May 28, 2024 UPC Weekly - Let’s talk about costs 2024 Week 21 This week we focus how the UPC is dealing with requests for security for costs and the ...
Simon Parry - May 20, 2024 Electric ships are here. But how to charge them? Ports need to supply ships with megawatts of power to charge in under two hours. The BlueStor ...
Matthew Naylor - May 20, 2024 UPC Weekly - UPC Court of Appeal confirms their own case law on claim interpretation but sidesteps question of file wrapper estoppel 2024 Week 20 The UPC Court of Appeal have issued another decision on a preliminary injunction – ...
Alex Burns - May 16, 2024 English Courts consider the patentability of AI My colleague, Rebecca Frith and I viewed the Court of Appeal hearing in the Emotional Perception AI ...
Callum McGuinn - May 14, 2024 Capturing solar and wind: how Geyser Batteries can balance the grid The grid needs a rapid way to balance input and output. Geyser Batteries of Finland may have the ...
Matthew Naylor - May 13, 2024 UPC Weekly - High bar to challenge the jurisdiction of the UPC 2024 Week 19 This week saw the UPC issue two decisions about its own jurisdiction. Where a ...
Amelia Jones - May 13, 2024 Bacteria bites back: Putting carbon on the menu When faced with solving the climate crisis, no idea is too ambitious for Synthetic Biology (SynBio) ...
Matthew Naylor - May 7, 2024 UPC Weekly - Preliminary injunctions at the UPC – get your defence ready 2024 Week 18 This week we look at a recent UPC first instance decision for a preliminary ...
Joanna Smith - May 1, 2024 Our clients are at the heart of our Trade Mark business We are delighted to release our latest brochure 'Our clients are at the heart of our Trade Mark ...
Matthew Naylor - April 22, 2024 UPC Weekly - Language of proceedings at the UPC 2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the ...
Matthew Naylor - April 15, 2024 UPC Weekly - Time-dependent transparency of UPC proceedings? 2024 Week 15 The week saw the Court of Appeal issue its decision on public access to court file ...
Matthew Naylor - April 10, 2024 UPC Weekly - Mind your costs 2024 Week 14 The UPC Court of Appeal issued a collection of five appeal decisions on 3 April 2024 ...
Matthew Naylor - April 3, 2024 Public access to UPC proceedings When the UPC was set up, a basic tenet was set out in Article 45 of the UPC Agreement, that the ...
Katherine Collins - April 2, 2024 Efficiency in Expansion: Meeting the Scale-Up Challenge in Cell and Gene Therapies One of the pivotal challenges in the development and commercialisation of cell and gene therapies ...
Anthony Judd - April 2, 2024 EPO related support measures for small entities – 1 April 2024 INTRODUCTION From 1 April 2024, the EPO are introducing a new fee reduction scheme specifically for ...
Christoph Moeller - March 28, 2024 Design rights can build IP protection, EU Lego ruling shows Featuring in Law360, Christoph Moeller explores the recent EU Lego ruling and how it serves as a ...
Fay Allen - March 27, 2024 Endometriosis - research, diagnosis and treatment progress March is Endometriosis Action Month, and this year’s focus is on raising awareness.
Edward Couchman - March 25, 2024 Cancer-killing bacteria: past, present and future While bacteria have frequently made the medical news in recent years due to the urgent problem of ...
Amin Zouine - March 22, 2024 From grass to graphene: could methane answer the call for rising nanomaterial demand? Methane, the principal component in natural gas, accounts for approximately a third of the ...
Christoph Moeller - March 20, 2024 EU design protection rules modernised for new technologies and circular economy On 14 March 2024, the European Parliament approved modernised EU design protection rules to adapt ...
Callum Anderson - March 13, 2024 Can AI help to improve the biopsy process for patients? In medicine, a biopsy is a procedure that involves taking a small sample of body tissue so it can ...
Lucy Coe - March 11, 2024 Challenging patents and other clearance actions in Europe Whether it is to remove a current infringement threat, clear the way to reduce the risk in ...
Andy King - March 8, 2024 Navigating the Sonic Maze: overcoming the challenges with registering sound marks in the UK In an increasingly crowded market, businesses are recognising the value of sound marks (or ‘sonic ...
Daniel Brodsky - March 8, 2024 Robotics in surgery For many, the word ‘surgery’ suggests images of surgeons operating with handheld instruments ...
Andrew Fearnside - March 6, 2024 Inside Silicon Quantum Computing: an interview with Komal Pahwa Senior IP counsel Komal Pahwa reveals how Australia's star quantum startup is building a silicon ...
Callum Anderson - March 6, 2024 Laparoscopic AI AI in the OR Copying music, making bad art and training the next generation of surgeons, just some ...
Laura Pediani - March 6, 2024 Meet the team: Laura Pediani, Patent Paralegal As part of our 'meet the team' series, we talk to paralegal Laura Pediani about client service, ...
Richard Johnson - March 4, 2024 New partner and IP director promotions We are delighted to announce the appointment of Anna Mudge, Ben Boyd, Daniel Brodsky, Isobel Stone ...
Nick Sutcliffe - March 4, 2024 Cellular Agriculture – Innovating through the Challenges The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...
Eliot Ward - February 29, 2024 The link between the microbiome and chronic liver disorders Guts UK is the charity for the digestive system. It funds scientific research such as Nicholas ...
Maria Hall - February 29, 2024 British Science Association CREST Discovery Day in our Bristol office On Tuesday 20 February 2024, we were thrilled to welcome 28 students from Kings Oak Academy to our ...
Rebecca Brooks - February 29, 2024 Updates to the Guidelines for Examination at the EPO The Guidelines for Examination at the EPO (which will be referred to as “the Guidelines” in this ...
Sarah Morrow - February 29, 2024 UKIPO Green Technology Report 2024 When the UK set a legally binding target to reach net zero greenhouse gas emissions by 2050, it was ...
Jacqueline Murphy - February 29, 2024 Women in IP Global Networking Event 18 April 2024 We are delighted to be hosting an in person global networking and discussion event to celebrate ...
Matthew Barton - February 29, 2024 Sodium alternatives to lithium-ion batteries? Na, we’re not Li-ion! The importance of lithium ion (Li-ion) batteries in modern society is no secret. They dominate the ...
David Brooks - February 27, 2024 Graphene Medtech: The Next Frontier It has been 20 years since Andre Geim and Konstantin Novoselov first isolated graphene: the two ...
Katie Dale - February 26, 2024 Top marks for Iovance as FDA approves first-in-class cell therapy Amtagvi for solid tumours On February 16, 2024, a real milestone was reached in the cell therapy field, as the FDA approved ...
Isobel Fisher - February 22, 2024 Colony picking robot expands our knowledge of human gut microbiome The human microbiome is very diverse. A typical gut microbiome can contain hundreds or even ...
Foteini Tzakoniati - February 22, 2024 Antibody inventions: Updates in the EPO Guidelines for Examination The EPO Guidelines for Examination are set to undergo updates effective from 1 March 2024. The ...
Christoph Moeller - February 21, 2024 Meet the team: Christoph Moeller, Partner, Patent Attorney As part of our 'meet the team' series, we talk to Christoph Moeller, partner in our Munich office, ...
Eliot Ward - February 21, 2024 Biological Deposits under the Budapest Treaty (1977): important considerations for filing strategies and public accessibility Biological material, which the EPO understands to be any material containing genetic information ...
Natascha Newbold - February 19, 2024 Meet the Team: Natascha Newbold, IP Support, Trade Mark Paralegal As part of our 'meet the team' series, we talk to trade mark paralegal Natascha Newbold about her ...
Maria Hall - February 15, 2024 Mewburn Ellis achieves Menopause Friendly Accreditation We are proud to have been awarded the Menopause Friendly Accreditation, established by Henpicked: ...
Tom Furnival - February 14, 2024 The major players in the SEP landscape in Europe Next in our series of blogs, we have investigated the major players in the SEP landscape in Europe.
Callum Anderson - February 13, 2024 Advances in Positron Emission Tomography (PET) Scans Positron Emission Tomography (PET) is a non-invasive technique for imaging inside of the body. It ...
Alice Jefferies - February 13, 2024 Blooming bright! Bioluminescent plant set to brighten up flower beds across the US The green fingered among us take great pride in our blossoming gardens and house plants; those, ...
Frances Salisbury - February 8, 2024 Yoni Health: the medical secrets of menstrual blood Menstrual effluent contains a wealth of scientific info, including biomarkers for endometriosis, ...
Sarah Harvey - February 8, 2024 European Parliament votes to endorse plants bred using New Genomic Techniques 7 February 2024 marked a milestone for plant science as the European Parliament (EP) voted to ...
Lesley Gardner - February 8, 2024 Lucie Jones appointed to CIPA IP Paralegal Committee Congratulations to Lucie Jones on her appointment to the Chartered Institute of Patent Attorneys ...
Edward Couchman - February 7, 2024 Genes as Medicines: Treating the Untreatable In 2023, gene therapy hit the headlines in the UK, when the BBC reported the cure of a toddler with ...
Amelia Jones - February 7, 2024 Fertile Ground: Tapping into the Potential of the Female Microbiome Healthcare systems around the world have historically been designed by men, with “white males” ...
Anthony Judd - February 6, 2024 EPO announces fee increases from 1 April 2024 In recent times, the European Patent Office (EPO) has increased its official fees every two years, ...
Frances Salisbury - February 6, 2024 Meet our Women’s Champion: Fran Salisbury Even the most progressive firm can improve working life for women.
Eleanor Maciver - February 2, 2024 Mewburn Ellis is delighted to partner with Oxfordshire Greentech on the Climate Solutions Conference Mewburn Ellis is delighted to partner with Oxfordshire Greentech on the Climate Solutions ...
Rebecca Blundell - February 2, 2024 Sustainable shoes: Fossil Fuels are so last year! It is estimated that 24 billion pairs of shoes are made every year. Many of these will contain ...
Katherine Green - February 2, 2024 Most opposed patents of 2023 Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ ...
Sarah Harvey - January 31, 2024 Hydrogels in sustainable agriculture As we move into 2024, the agricultural sector is being driven by the urgent need to address global ...
Thomas Lonsdale - January 30, 2024 Plant based leather - the eco-friendly alternative hitting the catwalks Vegan leather isn’t only an ecofriendly alternative, which isn’t made from animals. It’s also being ...
Emily Lythell - January 26, 2024 Gouda vibes only – AI cooks up vegan meat and cheese alternatives The Kraft Heinz Company has recently introduced three new vegan sliced cheese varieties in the ...
Philippa Schofield - January 24, 2024 Meet The Team: Philippa Schofield, IP Support Services, Paralegal Manager As part of our 'meet the team' series, we talk to paralegal manager Philippa Schofield about ...
Jamie Emerick - January 24, 2024 High Court confirms EU law does not prohibit use of ‘milk’ in a trade mark for milk substitutes in the UK Last year, in December 2023, the Chancery Division of the High Court handed down its decision on ...
Rebecca Brooks - January 22, 2024 One Health and the role of the microbiome Traditionally, clinical microbiology focused on the role of individual microbes in human and animal ...
Jacqueline Murphy - January 18, 2024 Design Rights: A powerful tool in the IP armoury We are pleased to launch our latest special report Design Rights: A powerful tool in the IP ...
Joe Egelstaff - January 16, 2024 AI bias in healthcare AI tools are increasingly being used in healthcare settings, with applications ranging from ...
Sophie Chua - January 16, 2024 Gigafactories & IP: Protecting the processes that power the future As the use of electric vehicles (EVs) becomes increasingly prevalent, demand for batteries is set ...
Lauren Woolley - January 11, 2024 Eat your greens: innovations in sustainable alternative protein sources As the demand for plant-based products continues to grow, so too does the rate of advancement in ...
Naomi Armitage - January 11, 2024 Meet The Team: Naomi Armitage, IP Support Services Trainer As part of our 'meet the team' series, we talk to IP Support Services Trainer Naomi Armitage about ...
Emily Sullivan - January 9, 2024 Pharma trade marks: 2023 EU case law round up As we enter 2024, we reflect on the lessons we have learned in 2023. The trade mark landscape has ...
Alexander Savin - January 8, 2024 Nuclear Fusion: A Case Study in the need for a cohesive IP Strategy at the forefront of science Following on the continued success in inertial confinement research reported from the National ...
Emily Lythell - January 5, 2024 Antibiotic with novel mechanism offers new hope for treating resistant infections This week saw the publication of a potential new class of antibiotics and their mechanism ...
Robert Andrews - January 4, 2024 Podcast with Robert Andrews: a forward-thinking approach to inclusion & diversity Robert Andrews joins Lisa Mueller and Vivian Luiz Coco on their Inclusion Evolution podcast to ...
Thomas Lonsdale - January 3, 2024 Plastic Packaging Pollution: Kelp is on the Way! Plastic packaging materials have revolutionised modern life. They have several important properties ...
Lauren Woolley - January 3, 2024 Mewburn Ellis is proud to be participating in Veganuary (again) Following last years’ success, we will once again be taking part in the Veganuary Workplace ...
Simon Kiddle - January 2, 2024 The wonderful potential of waxworm saliva Enzymes are able to break up plastic, opening the way for rapid recycling.
Emily Hayes - December 20, 2023 Amended Rules of Procedure of the EPO Boards of Appeal are coming into force on 1 January 2024 The EPO Boards of Appeal have now published their amended Rules of Procedure and these will be ...
David Brooks - December 20, 2023 UK Battery Strategy Commentary Ahead of the Global Investment Summit hosted recently in November 2023 at Hampton Court Palace, the ...
Joseph Newcombe - December 19, 2023 The Royal Institution's new mission With 1.4 million subscribers on YouTube, the organisation is finding new ways to enthuse the ...
Callum Anderson - December 19, 2023 Gazing into the future of augmented reality glasses Augmented reality (AR) sits between virtual reality (VR) and the real world.
Alice Jefferies - December 19, 2023 Synthetic probiotics: bacteria that link the gut to the brain Optimising pharmacokinetics of a drug is a vital stage of the development process. Pharmacokinetics ...
Tom Furnival - December 19, 2023 How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3 This article continues our series of blogs investigating whether or not declaring your patent or ...
Ben Boyd - December 19, 2023 Sailing cargo You might question why an IP firm concerned with innovation is writing about the use of sails in ...
Eleanor Maciver - December 18, 2023 Saved by the cell: taking the animals out of meat Entrepreneur Joshua Errett is aiming to remove animals from the food chain. His first move is to ...
Lucie Jones - December 18, 2023 The Ghosts of Paralegals Past, Present and Future Going back in time Let me take you back at the beginning of the century. Christmas 2001 is just ...
Calum Graham - December 14, 2023 National Vision for Engineering Biology On Tuesday 5 December 2023, the Minister for Science, Research and Innovation, Andrew Griffith MP, ...
Joseph Newcombe - December 12, 2023 New highs for psychedelics in the clinic Psychedelic compounds have long been experimented with for their mind-altering properties, but in ...
Shajila Aziz - December 6, 2023 Meet The Team: Shajila Aziz, Patent Administrator As part of our 'meet the team' series, we talk to patent administrator, Shajila Aziz about her ...
David Brooks - December 5, 2023 Layering up: how graphene is disrupting the sportswear industry Earlier this year, Novak Djokovic broke the men’s tennis record for the most Grand Slam tournament ...
Ben Boyd - December 5, 2023 Ballast-free ships While this blog is about ballast-free ships, it is important to understand why cargo ships require ...
Amelia Jones - December 4, 2023 Enzyme-based carbon capture: as easy as breathing Over the past few years, the impact of the climate crisis has never been far from the front pages. ...
Lucy Coe - December 4, 2023 EPO will accelerate oppositions when there are parallel UPC infringement or revocation proceedings The EPO have announced in the November 2023 Official Journal that they will accelerate opposition ...
Joanna Smith - November 30, 2023 Mewburn Ellis recognised in The Legal 500 UK Green Guide 2024 We are delighted to announce that we have been recognised in The Legal 500 UK Green Guide 2024 ...
Sean Constable - November 30, 2023 Practical tips for EPO appeal proceedings under the new, stricter rules: 5 key takeaways from a recent EPO conference In 2020 the EPO revised the rules that govern the procedure at the EPO Boards of Appeal. As we ...
Sarah Morrow - November 29, 2023 What is Graphene? For an undergraduate scientist, the answer to the question “What is graphene?” is perhaps all ...
Niles Beadman - November 28, 2023 Invention Capture: 5 Steps to Success - Transforming Technology to Patent Protection Invention capturing, also referred to as invention harvesting or invention mining, is the start of ...
Alex Burns - November 28, 2023 Emotional Perception AI v UKIPO: Is this the dawning of a new era for AI-related inventions at the UKIPO? On 21 November 2023, Mann J handed down his judgment on Emotional Perception AI Ltd v ...
Ben Boyd - November 23, 2023 Tidal energy Most people are aware that the moon (and to a lesser extent the sun), exert a gravitational pull on ...
Tamara Rubery - November 22, 2023 Meet The Team: Tamara Rubery, Senior HR Manager As part of our 'meet the team' series, we talk to senior HR manager, Tamara Rubery about being ...
Rob Walker - November 21, 2023 Mewburn Ellis announce carbon offsetting for 22 – 23 financial year As a business, we have made several commitments about our environmental impact, and in particular ...
Emily Lloyd - November 17, 2023 Latest Medtech developments in the race to help diabetes sufferers November is National Diabetes Awareness month and, in this blog, we are discussing the latest ...
Maria Hall - November 17, 2023 Bristol office selects Springboard Opportunity Group as their chosen charity to support This year, our Bristol office voted for Springboard Opportunity Group as their office charity. We ...
Alex Galbraith - November 17, 2023 The first CRISPR treatment – Casgevy wins UK approval for sickle cell disease In a world first, the UK medicines regulator has given the green light to a therapy employing ...
Eleanor Maciver - November 17, 2023 The polymathic Professor Michael Shaver The maverick scientist leads the SMI Hub in Manchester. He’s bringing together environmentalists, ...
Isobel Fisher - November 17, 2023 Biosensor bacteria for tumor detection Genetically engineered biosensor bacteria could allow us to detect colon cancer without the need ...
James Leach - November 16, 2023 IP Protection for software-based products- An Introduction for SMEs We are excited to launch our new software resource booklet — 'IP Protection for software-based ...
Jamie Emerick - November 15, 2023 EU General Court provides guidance on consumer perception in the pharmaceutical industry Earlier this year, in March 2023, the European Union’s General Court provided some useful ...
Ben Boyd - November 14, 2023 Salinity gradient power In this series on capturing energy from the ocean we’ve recently discussed wave power, tidal power ...
Katherine Green - November 13, 2023 Most opposed patents of 2022 As with CRISPR, patents directed to Nobel Prize-winning technologies are viewed as extremely ...
Rachel Collier - November 9, 2023 Meet the Team: Rachel Collier, IP Support, Paralegal As part of our 'meet the team' series, we talk to paralegal Rachel Collier about her commitment to ...
Jacqueline Murphy - November 8, 2023 Validating European patents outside Europe - the Validation State system We are pleased to launch our latest report Validating European patents outside Europe - the ...
Ben Boyd - November 7, 2023 Is Ocean Thermal Energy Conversion a sustainable way forward? We’ve previously discussed how energy can be captured directly from the movement of the waves on ...
Joe Egelstaff - November 6, 2023 Total artificial hearts: creating the perfect pump Cardiovascular disease is estimated to account for 45% of deaths in Europe each year. More ...
Katie Dale - November 6, 2023 Swapping in stem cells for diabetes treatment With just under 50% of type 1 diabetes patients using wearable blood glucose monitors1, medical ...
Rhiannon Wescott - October 31, 2023 Check out the Mewburn Forest! We committed to plant a tree for every new matter we’ve opened since April 2021. Two-and-a-half ...
Nathan Zhang - October 24, 2023 After the road: how to recycle old tyres With a billion tyres going to the scrapheap each year, the industry is seeking to end the waste. ...
Jacqueline Murphy - October 23, 2023 In person event - Circular Economy: Ideas to Business, Oxford, 7 December 2023 Mewburn Ellis is delighted to be partnering with Oxfordshire Greentech to present an exciting in ...
Richard Clegg - October 23, 2023 Andy King appointed as Head of Trade Marks and joins the firm’s Management Board We're pleased to announce that Partner Andy King will be the new Head of the Trade Mark Practice ...
Lesley Gardner - October 23, 2023 Meet the Team: Lesley Gardner, Business Services, Head of IP Support Services As part of our 'meet the team' series, we talk to Head of IP Support Services Lesley Gardner about ...
Joanna Smith - October 20, 2023 WIPR Diversity 2023 We are delighted to have three of our wonderful women recognised in WIPR Diversity 2023. WIPR ...
Joanna Smith - October 20, 2023 Lucy Coe appointed Women in IP Committee Lead for IP Inclusive Congratulations to Lucy Coe on her appointment as IP Inclusive: Women in IP Committee Lead.
Simon Parry - October 19, 2023 Major developments in the UK offshore wind farm industry October has been a busy and exciting month for offshore wind news in the United Kingdom.
Joanna Smith - October 19, 2023 Chambers & Partners 2024 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2024 legal ...
Simon Kremer - October 13, 2023 The EPO’s Enlarged Board of Appeal decides how the EPO should assess entitlement to priority The Enlarged Board of Appeal of the EPO has now issued its long-awaited answers to the legal ...
Lucy Coe - October 11, 2023 Meet the Team: Lucy Coe, Senior Associate, Patent Attorney As part of our 'meet the team' series, we talked to Lucy Coe about her passion for science, the ...
Matthew Barton - October 6, 2023 Recycling the Rainbow - coloured plastics in the circular economy Single-use plastic has become indispensable in everyday life, particularly in the packaging of ...
Rebecca Brooks - October 6, 2023 Supporting Guts UK and their research into the gut microbiome We’re pleased to announce that we have started a new charity partnership with Guts UK. Guts UK was ...
Kate O'Rourke - October 5, 2023 Chartered Trade Mark Attorneys – your key business ally In the past few years there has been an upsurge in the number of unqualified and unregulated ...
Joanna Smith - October 5, 2023 Mewburn Ellis: top tier firm Legal 500 2024 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Eliot Ward - October 4, 2023 UPC at four months old - a review The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...
Joanna Smith - October 4, 2023 Congratulations to our Rising Stars 2023 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Nick Sutcliffe - October 3, 2023 Covid autumn booster vaccine 2023: the switch to mono-valent vaccines Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.
Nathan Zhang - October 3, 2023 Taking (personal) care of the future The market size of beauty and personal care is huge, valued at a global revenue of over $570 ...
Sean Jauss - September 29, 2023 Beware the front-loaded procedure! The Unified Patent Court (‘UPC’) opened its doors on 1 June 2023. It is a new court in the European ...
Sydney Phillips - September 27, 2023 Meet The Team: Sydney Phillips, IP Support Services, Paralegal As part of our 'meet the team' series, we talk to patent paralegal, Sydney Phillips about time ...
Sarah Harvey - September 21, 2023 UK regulators decide preferred approach to precision bred crops Yesterday (Wednesday 20 September 2023), the Food Standards Agency board decided on their preferred ...
Tom Furnival - September 20, 2023 How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 2 This article is the latest in a series of blogs exploring whether declaring your patent or ...
Thomas Lonsdale - September 19, 2023 Not just window dressing: the technologies making textiles greener Not only are textiles the biggest source of microplastics globally, supplying the world’s clothing ...
Maria Hall - September 19, 2023 Mewburn Ellis praised for achievements in sustainability EcoVadis ratings highlight environmental policies and sustainable procurement practices alongside ...
Sean Jauss - September 13, 2023 Meet The Team: Sean Jauss, Partner, Solicitor, Litigator, Head of Legal Services As part of our 'meet the team' series, we talk to head of legal and dispute resolution, Sean Jauss, ...
Matthew Smith - September 8, 2023 Trends in Graphene IP – a refresh Last year, we delved into the data to see how the number of patent publications coming out had ...
Rebecca Anderson-Smith - September 7, 2023 A badge of green credentials With consumers increasingly choosing brands that are more environmentally friendly, we have seen a ...
Kirsty Morris - September 7, 2023 Meet The Team: Kirsty Morris, IP Support Services, Patent Administrator As part of our 'meet the team' series, we talk to patent administrator, Kirsty Morris about her ...
David Brooks - September 6, 2023 Graphene: permeating the hydrogen economy The growth of the so-called “hydrogen economy” is crucial to achieving net-zero carbon emissions ...
David Brooks - September 6, 2023 IP audits for battery and energy storage businesses Companies working in the fields of batteries and energy storage often have a wealth of intellectual ...
Alice Jefferies - September 5, 2023 A leap forward in slowing down Alzheimer’s This summer has seen a major leap forward in slowing the rate of progression of Alzheimer’s disease.
Joseph Newcombe - September 5, 2023 Meet The Team: Joseph Newcombe, Associate and Patent Attorney, Sustainable Pharma Commentator As part of our 'meet the team' series, we talk to Joseph Newcombe about being involved in the ...
Maria Hall - September 5, 2023 Mewburn Ellis donate £219,000 to charity partnerships for 2023/2024 — over £790,000 donated since 2020 To mark the International Day of Charity (September 5th), we are delighted to announce a commitment ...
Rebecca Anderson-Smith - September 1, 2023 Building an international Customs strategy for your pharma brand Counterfeit pharmaceuticals are a global problem and pose a significant threat to consumers and ...
Alex Galbraith - September 1, 2023 Gene therapy – the status quo and future trends The uptick in recent approvals in the gene therapy space is emblematic of a field which is now ...
Emily Sullivan - August 31, 2023 Understanding parallel import of pharmaceuticals in the EU – a quick guide to repackaging and relabelling of parallel imports for brand owners Parallel importing, the practice where third parties import branded goods already put on sale by ...
Maria Hall - August 31, 2023 Cambridge office selects Cambridge City Foodbank as their chosen charity to support Our Cambridge office has chosen Cambridge City Foodbank as one of our local charities and we have ...
Maria Hall - August 30, 2023 A visit to The Booth Centre — Manchester office to support charity over next two years The Booth Centre is a charity that our Manchester Office have chosen to support over the next two ...
Hojae Lee - August 30, 2023 Updates on the Korean Intellectual Property Office (KIPO) fee structure, effective 1 August 2023 If you have patents or trade marks in Korea or are considering filing or transferring them, you ...
Maria Hall - August 29, 2023 Meet The Team: Maria Hall, Business Services, Chief M&BD Officer, Community Champion As part of our 'meet the team' series, we talk to chief marketing and business development officer ...
Karolina Fryzlewicz - August 25, 2023 Strategic Pharmaceutical Branding: when should you apply to register a trade mark if still undergoing clinical trials? Tying trade mark considerations into your drug development strategy can be a rather challenging ...
Eleanor Maciver - August 23, 2023 Mewburn Ellis Net-Zero Targets Validated by Science Based Target initiative As part of our ongoing commitment to environmental sustainability, we are proud to have our near ...
Simon Parry - August 23, 2023 Is the future in the wind? Pyxis Ocean sets sail! This week we have seen the bulk carrier Pyxis Ocean set sail (literally!) for the first time with ...
Andrew Fearnside - August 21, 2023 The world beyond quantum computing Infleqtion is developing the next generation of quantum tools, including clocks, gravimeters and ...
Fynn McLennan - August 21, 2023 Silicon anodes: where are we now? In 2020, we wrote about some of the approaches being taken to develop viable silicon-based anodes. ...
Maria Hall - August 16, 2023 Mewburn Ellis support Jonathan's Voice for third year, donating £50,000 so far “The focus of our I&D strategy is building inclusion, we are aiming to do this by ensuring that ...
James Leach - August 16, 2023 Quick guide to determining whether a software invention is patent eligible. In general, the main obstacle to obtaining patent protection for a new software invention is the ...
Kimberley Harding - August 16, 2023 Meet The Team: Kimberley Harding, IP Support, Paralegal As part of our 'meet the team' series, we talk to paralegal, Kim Harding about studying for patent ...
Maria Hall - August 16, 2023 Our LGBTQ+ Group selects All About Trans as one of their chosen charities to support. This year, our LGBTQ+ group has chosen All About Trans as one of their charities to support for our ...
Maria Hall - August 16, 2023 London office selects The National Brain Appeal as their chosen charity to support. This year, our team in London have voted for The National Brain Appeal as their office charity. We ...
Adam Gregory - August 11, 2023 VC tips for SMEs — how do VCs evaluate the value of intellectual property? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Tom Furnival - August 10, 2023 UPC as a forum for SEP disputes – Panasonic kick off proceedings With the UPC opening its doors just over two months’ ago, the IP profession has been keenly ...
Fay Allen - August 10, 2023 In vivo expression of chimeric antigen receptors: using gene therapy to improve cell therapy In vivo CAR therapies build on the success of standard CAR treatments and aim to overcome the ...
Julie Carlisle - August 10, 2023 Mewburn Ellis team up with Support Dogs to sponsor an Assistance Dog This week (7 – 13 August 2023) is International Assistance Dog Week and this year we're excited to ...
Ine Vanderleyden - August 9, 2023 The next-generation therapies for autoimmune diseases The immune system has an extraordinary capacity to distinguish “self” from “non-self”. This means ...
Alexander Savin - August 9, 2023 Nuclear fusion breakthrough raises hope for limitless clean energy A research team at Lawrence Livermore National Laboratory (LLNL) in California USA has reportedly ...
Niles Beadman - August 8, 2023 Superconductor sparks excitement, but meets resistance The last few weeks have seen the rise of an unlikely social media star – the claimed ...
Edward Couchman - August 7, 2023 Cells as medicines: the promise of cell therapy Cell therapy is one of the most exciting areas of medical science, with recent years having seen ...
Tom Furnival - August 7, 2023 How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? This article is the latest in a series of blogs exploring whether declaring your patent or ...
Maria Hall - August 4, 2023 Mewburn Ellis support CREST Awards for the third year donating £128,000 so far We now enter our third year of supporting the British Science Association and their CREST Awards ...
Rebecca Anderson-Smith - August 4, 2023 Court of Appeal confirms filing a trade mark cancellation action does not ‘stop the clock’ on acquiescence In our “Pharma trade marks: 2022 case law round up” (written towards the end of November 2022) we ...
Clare James - August 2, 2023 Meet The Team: Clare James, Business Services, Executive Assistant As part of our 'meet the team' series, we talk to Clare James, EA to the Mewburn Ellis management ...
Edward Couchman - August 1, 2023 US Supreme Court Upholds Tightening of Patent Enablement Standard In an eagerly awaited judgement, the US Supreme Court has affirmed the standard applied by the ...
Thomas Lonsdale - July 31, 2023 Green Aviation – Ready for Take off! In 2022 aviation accounted for ca. 2% of global energy-related CO2 emissions, with around 800 Mt ...
Lesley Gardner - July 26, 2023 National Paralegal Awards Finalists 2023 We are extremely proud to announce our finalists in the National Paralegal Awards 2023 which ...
Nick Sutcliffe - July 26, 2023 IP priorities for forward-looking cell and gene therapy businesses IP priorities are especially important to businesses developing advanced therapeutic products. ...
Maria Hall - July 26, 2023 Developing our online services to meet your needs Our clients choose to work with us because we offer fresh insights and business-minded solutions. ...
Karolina Fryzlewicz - July 19, 2023 How to mobilize your IP rights in the fight against counterfeit goods: Customs Application for Action ‘Imitation is the sincerest form of flattery’ is a motto that does not fare well with intellectual ...
David Brooks - July 19, 2023 Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022 Last year we reported the unprecedented growth of the innovative pharmaceuticals industry in 2021 ...
Eleanor Gooding - July 18, 2023 Meet The Team: Ellie Gooding, IP Support, Paralegal As part of our 'meet the team' series, we talk to paralegal, Ellie Gooding about being part of a ...
Jacqueline Murphy - July 18, 2023 Does Green IP mean go? Exploring acceleration under the UKIPO’s “Green Channel” We are pleased to launch our latest report Does Green IP mean go? Exploring acceleration under the ...
Alexander Cavell - July 17, 2023 Developing battery technology? Think inside the Box! The Patent Box is a tax break scheme that is designed to encourage companies, such as those ...
Eliot Ward - July 14, 2023 The secrets of the oral microbiome More than 700 species of bacteria live in our mouths. The mysteries of this ecosystem are now being ...
Thomas Driver - July 13, 2023 Evolution of engineered minimal cells - high mutation rates and regained fitness Engineered bacterial cells with minimal genomes were developed in 2016 - these minimal cells ...
Alice Jefferies - July 10, 2023 Mewburn Ellis lace up for Endure24 in support of East Anglia’s Children’s Hospices Mewburn Ellis showed steely determination to complete a 24-hour running challenge, raising £2,500 ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Nick Sutcliffe - July 6, 2023 VC tips for SMEs — how to choose the right VC? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Maria Hall - July 6, 2023 £20,000 support for FoodCycle to help address the cost of living crisis. This year we have chosen to support FoodCycle as one of our firmwide charities and have made a ...
Thomas Wolter - July 6, 2023 Beating the Punch: UPC Protective Letters The Unified Patent Court (UPC) is now operational. As of June 1, 2023, patentees can enforce ...
Sean Jauss - July 5, 2023 Litigation in the Unified Patent Court (UPC) The UPC is a new European patent litigation court. It will provide a single forum for the ...
Ben Boyd - July 5, 2023 Big Data in Maritime transport Big data has been a big thing for most of the last decade, yet its importance in industry continues ...
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Karolina Fryzlewicz - July 4, 2023 Protecting yourself against IP scammers Scamming practices, such as misleading invoices and spoofed phone calls, are unfortunately a part ...
Davina Lockyer - July 3, 2023 Meet The Team: Davina Lockyer, Business Services, System Accountant As part of our 'meet the team' series, we talk to system accountant, Davina Lockyer about why she ...
Sean Jauss - June 27, 2023 UPC Administrative Committee approves Milan as host of the third Central Division court The UPC Administrative Committee has announced that Milan will host the third seat of the UPC’s ...
Jacqueline Murphy - June 26, 2023 In person event - Circular Economy: Ideas to Business, Cambridge, 13 September Mewburn Ellis is delighted to be partnering with Cambridge Cleantech to present an exciting in ...
Adam Gregory - June 22, 2023 Cell-cultivated chicken approved for sale in US On Wednesday 21 June 2023, the United States Department of Agriculture (USDA) approved the sale of ...
Isobel Fisher - June 22, 2023 One giant leap for plant-kind: engineering plants for Mars If humans are going to live on Mars one day, we need to work out how to grow plants there. Plants ...
Debbie Williams - June 21, 2023 Meet The Team: Debbie Williams, IP Support, Paralegal As part of our 'meet the team' series, we talk to paralegal Debbie Williams about developing her ...
Lisa Sharma - June 20, 2023 Making plastic disappear It comes as no surprise, that single-use plastic remains one of the most pressing environmental ...
David Fyfield - June 19, 2023 IPEC Small Claims moving to Manchester The Presiding Judge of the Intellectual Property Enterprise Court (‘IPEC’) has issued a Practice ...
Matthew Smith - June 12, 2023 Meet Ava Garside, teenage graphene innovator Ava Garside first created her pollution sensor badge aged 12. Now she's pushing the boundaries of ...
Cat Bate - June 8, 2023 Meet The Team: Cat Bate, Business Services, Learning & Development Manager As part of our 'meet the team' series, we talk to learning and development manager, Cat Bate about ...
Karolina Fryzlewicz - June 8, 2023 Katy Perry v Katie Perry: Use of famous personalities’ names in commerce Brand owners who build brands under their own name unsurprisingly attach great importance to how ...
Rob Walker - June 7, 2023 World Ocean Day 2023 – Turning the Tide on Ocean Pollution 8 June 2023 marks the 21st World Ocean Day, which, in the words of The Ocean Project, has a mission ...
Joanna Smith - June 6, 2023 More recognition in MIP IP Stars 2023 It is fantastic to once again be recognised in MIP IP Stars 2023. So far this year, we have ...
Emily Sullivan - June 2, 2023 EUIPO vs “EMMENTALER” Trade mark courts worldwide spend a good deal of time deciding what trade marks cheese ...
Rebecca Anderson-Smith - May 25, 2023 Meet The Team: Rebecca Anderson-Smith, Partner, Chartered Trade Mark Attorney As part of our 'meet the team' series, we talk to partner, Rebecca Anderson-Smith about how she set ...
Daniel Brodsky - May 23, 2023 Team Bath Racing Electric enters driverless car race at Silverstone Team Bath Racing Electric is set to hit the track at Formula Student 2023, including the Dynamic ...
Andy King - May 22, 2023 Meet The Team: Andy King, Head of Trade Marks, Chartered Trade Mark Attorney As part of our 'meet the team' series, we talk to partner and Head of Trade Marks Andy King about ...
Robert Andrews - May 22, 2023 Podcast with Robert Andrews: how to drive I&D progress and engage key stakeholders Robert Andrews joins Natasha Rainey on her All Inclusive Podcast to discuss his journey to becoming ...
Toby Hill - May 16, 2023 CREST Awards case study: an interview with Toby Hill Mewburn is a national partner for the CREST Awards programme run by the British Science Association ...
Jacqueline Murphy - May 16, 2023 Green Tech: Making IP Part of Your Toolkit - Webinar On Wednesday 21 June, we are delighted to be hosting in partnership with Oxfordshire Greentech a ...
Andy King - May 15, 2023 Percy Pig ice cream renamed after M&S request A small family-run ice cream parlour based in Hertfordshire has recently renamed its 'Perky Pig ...
Ben Boyd - May 12, 2023 Offshore wind's contribution to the world's energy demand In 2019 the International Energy Agency (IEA) estimated that the energy available worldwide from ...
Kate O'Rourke - May 11, 2023 Meet The Team: Kate O'Rourke, Partner, Chartered Trade Mark Attorney As part of our 'meet the team' series, we talk to Chartered Trade Mark Attorney, Kate O’Rourke ...
Rebecca Tollervey - May 9, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal: Part 2 – inventive step We have conducted a review of Board of Appeal decisions relating to antibody patents published ...
Joanna Smith - May 5, 2023 Mewburn Ellis shortlisted for two awards at the Managing IP EMEA Awards 2023 We are delighted to have been nominated in two categories by Managing IP at their EMEA Awards.
Alex Burns - May 5, 2023 Gene sequencing accelerates with custom hardware The cost to sequence a genome continues to drop exponentially. Over the past 20 years, the cost to ...
Alice Jefferies - May 4, 2023 The ball is rolling at the FDA for microbiome therapies The FDA was busy last week! Off the back of the first approval for faecal microbiota transplant ...
Jacqueline Pang - May 4, 2023 Meet The Team: Jacqueline Pang, Partner, Chartered Trade Mark Attorney As part of our 'meet the team' series, we talked to Jacqueline Pang about ChatGPT, the use of trade ...
Anna Mudge - May 4, 2023 The allogeneic advantage Bespoke cell therapies are expensive and time-consuming. Now allogeneic cell treatments offer a ...
Rob Walker - May 2, 2023 The History of Hydrofoils Since their introduction into the America’s Cup boats in 2013, hydrofoils have become familiar to ...
Jan Rether - May 2, 2023 Meet The Team: Jan Rether, Partner, Attorney at Law As part of our 'meet the team' series, we talked to Jan Rether, partner in the Munich office, about ...
Andy King - April 28, 2023 Fail to Prepare; Prepare to Fail: a discussion about representation issues at the UK IPO The UK IPO has recently introduced an important change to the rules on representation of certain ...
Joseph Newcombe - April 26, 2023 Joe Newcombe in PharmaTimes — new order In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks out to pharma’s ...
Joanna Smith - April 26, 2023 MIP IP STARS: Top 250 Women in IP 2023 Congratulations to Kate O'Rourke who has been recognised in Managing IP: IP STARS Top 250 Women in ...
Darena Slavova - April 25, 2023 EPO to Abolish “10-Day Rule” from 01 November 2023 Key Points: the “10-day rule” will be abolished and will not be applied in respect of European ...
Thea Toutoungy - April 21, 2023 The lithium rush: an unsustainable approach to sustainability? In recent years, the world has seen the significant consequences of our continued heavy dependence ...
Rebecca Anderson-Smith - April 20, 2023 High Court finds Tesco Clubcard Prices logo infringes Lidl’s trade mark The High Court of England and Wales yesterday (19 April 2023) held that Tesco has been infringing ...
Jacqueline Murphy - April 19, 2023 Operating in the circular economy: From idea to Business – our co-hosted event with Oxfordshire Greentech On Wednesday 22 March, we were delighted to co-host an in-person event with Oxfordshire Greentech ...
Ben Boyd - April 17, 2023 Offshore winds blow against Siemens Late last year Siemens Gamesa Renewable Energy A/S was unsuccessful in asserting infringement of ...
Alison Fugard - April 14, 2023 “Wood”n’t it be nice? - Turning over a new leaf in wood-based packaging For years, we have been aware of the need to reduce our reliance on plastic. But there is a reason ...
Ben Boyd - April 14, 2023 Patents at sea Patents are a territorial right. A UK patent provides you with a monopoly right for your claimed ...
Tom Furnival - April 13, 2023 Does declaring your patent or application as “essential to a standard” influence the outcome of that patent or application in Europe? This blog is the first in a series in which we explore standards essential patents using patent ...
Rob Walker - April 12, 2023 Blowing bubbles to cut drag and clean up shipping If someone told you their latest invention was a bubble blowing device, you might think that they ...
Karolina Fryzlewicz - April 5, 2023 When dragons come to court: why a children book’s author lost a case of copyright infringement against John Lewis “The dragon is a creature of myth, dating back to ancient times and found in cultures across the ...
Robert Watson - March 31, 2023 UK accession to the CPTPP - grace period exemption big boost for IP The UK government announced 5 years ago its intention to join the CPTPP (Comprehensive and ...
Joe McAlary - March 28, 2023 Can parallel importers apply registered trade marks to previously unbranded products? Towards the back end of last year, the Court of Justice of the European Union (CJEU) gave a series ...
Emily Sullivan - March 24, 2023 Spot the difference: where UK and German laws go astray Despite the harmonisation of trade mark law in Europe over the past decades, significant ...
Anna Mudge - March 21, 2023 Advanced Therapies Congress 2023 - five key themes Anna Mudge enjoyed a bustling two days at the Advanced Therapies Congress 2023 in London. Nine ...
Ben Boyd - March 21, 2023 Motion of the ocean - Wave energy converters The ocean covers 70% of the earth’s surface, so it is no wonder there is a significant attention at ...
Paul Dunne - March 21, 2023 Reborn! How a radical process will be able to give new life to unwanted boats There are around a million boats in the UK and eventually they will all need to be recycled. The ...
Lucy Coe - March 17, 2023 How neurodiversity can benefit the legal profession As part of our Thought Leaders series, we explore the unique perspectives neurodivergent ...
Eleanor Maciver - March 15, 2023 Mycelium, a natural wonder In an ever more eco-aware world, Ecovative is creating foam, fashion, face masks and food from ...
Jacqueline Murphy - March 14, 2023 Femtech: a growth industry - new special report We are delighted to release our latest report Femtech: a growth industry.
Sean Jauss - March 14, 2023 Trade Secrets in practice As part of our Thought Leaders series, Mewburn Ellis Partner and Head of Legal Services Sean Jauss ...
Nathan Zhang - March 13, 2023 Wearing down tyre emissions The amount of particulate material which comes out of an exhaust pipe of a car is relatively modest ...
Frances Salisbury - March 9, 2023 Mewburn Ellis celebrates International Women's Day 2023 8 March 2023 was International Women's Day (IWD) which looks to celebrate women's achievements, ...
Jacqueline Murphy - March 7, 2023 Come and join us for a ‘Celebration of all things Singapore’ We are excited to be in Singapore for INTA 2023 and very much hope that you can join us at our ...
Chris Denison - March 6, 2023 Cheese without cows How Better Dairy are creating products that are molecularly identical to traditional dairy (without ...
Matthew Barton - March 3, 2023 Conservation innovation – working towards a world for both humans and wildlife With a rapidly growing human global population, predicted to reach 10 billion by 2057, our impact ...
Robert Watson - March 2, 2023 Julie Carlisle and Robert Watson in PharmaTimes — everything I own? Featured in PharmaTimes, Julie Carlisle and Robert Watson dig deep into the maelstrom of ...
Alex Burns - March 2, 2023 Can an AI win copyright protection? As part of our Thought Leaders series, we explore artificial intelligence and copyright. Forward: ...
Urs Ferber - March 1, 2023 Unified Patent Court (UPC) FAQS – how do we make sure an opt-out request is valid? The delay of the opening of the Unified Patent Court (UPC) gives us some additional time to reflect ...
Joseph Newcombe - March 1, 2023 Joe Newcombe in PharmaTimes — circle of life In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks out to pharma’s ...
Natalie Vaughan - February 23, 2023 Microbiome claims around the world: how to define your microbe? A booming commercial interest in harnessing the human microbiome for therapeutic uses has led to a ...
Niles Beadman - February 21, 2023 Faraday Battery Challenge: Funding the Future Michael Faraday uncovered the link between electricity and magnetism, built the first electric ...
Dan Thornton - February 20, 2023 The world’s toughest sports earbuds Tom Jelliffe is the founder of ultra-durable earphones brand Tzuka. Here’s how he took his concept ...
Ine Vanderleyden - February 20, 2023 Trafficking T cells – how to get cells to their target destination After being in the shadow of its famous relative, the antibody-producing B cell, for many decades, ...
Joanna Smith - February 20, 2023 WTR 1000 - The World’s Leading Trademark Professionals 2023 We are delighted be ranked silver for prosecution and strategy in WTR 1000 – The World’s Leading ...
Samuel Hart - February 17, 2023 EPO announces fee increases from 1 April 2023 In recent times, the European Patent Office (EPO) has increased its official fees every two years. ...
Eliot Ward - February 17, 2023 Germany completes ratification of UPC agreement, confirming the 1 June 2023 launch date Months of delay and uncertainty are finally behind us. Germany deposited its ratification of the ...
Urs Ferber - February 13, 2023 Unified Patent Court (UPC) FAQS – who is entitled to file an opt-out request? The delay of the opening of the Unified Patent Court (UPC) gives us some additional time to reflect ...
Paul Dunne - February 13, 2023 Plastics and climate change - a solution and a problem Plastics have the potential to play a crucial role in emission-saving technologies – from the ...
Frances Salisbury - February 10, 2023 Women and Girls in Science Day: Mewburn Ellis celebrates women in STEM fields Saturday 11 February 2023 marks the 8th International Women and Girls in Science Day.
Christopher Casley - February 9, 2023 AI and Tech innovation stands out in a slow year for pharma deals Last year saw a drop in the number and value of deals performed in the biotech and pharma sector ...
Callum McGuinn - February 8, 2023 Meet the team: Callum McGuinn, Partner and Patent Attorney in the Chemistry team, London As part of our 'meet the team' series, we talk to Callum McGuinn about his journey to becoming a ...
Maria Hall - February 7, 2023 Mewburn Ellis CREST Awards partnership report We are delighted to share our CREST Awards partnership project report. This outlines some of the ...
Karolina Fryzlewicz - February 6, 2023 Curing pharmaceutical trade mark deficiencies: EU guidance on “food supplements” and “pharmaceutical products” in Hasco TM v EUIPO Making genuine use of trade marks after registration is of fundamental importance to avoid the ...
Julie Carlisle - February 5, 2023 Meet the team: Julie Carlisle, Partner, Patent Attorney and Litigator in the Chemistry team, London As part of our 'meet the team' series, we talk to Julie Carlisle about her journey to becoming a ...
Lauren Woolley - February 3, 2023 Veganuary: what a month it has been! Veganuary is done for another year. What a month it has been!
Sarah Harvey - February 3, 2023 Veganuary: what we eat - 5 tips for sustainability As Veganuary comes to a close, we are preparing to return to our normal lives and, indeed, diets. ...
Callum Anderson - February 3, 2023 Getting to grips with device led physical rehabilitation innovation In the UK, there are an estimated 187,000 children living with an arm disability, and 85 million ...
Emma Graham - February 2, 2023 Meet the team: Emma Graham, Partner and Patent Attorney in the Engineering team, London As part of our 'meet the team' series, we talk to Emma Graham about her love of patent drafting, ...
Emma Graham - February 1, 2023 Should I file third party observations? A study of the consequences of filing third party observations (TPOs) in the MedTech sector and the ...
Rebecca Tollervey - February 1, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal The prosecution of patent applications relating to antibodies involves particular considerations. ...
Camille Terfve - January 31, 2023 Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge As part of our 'meet the team' series, we talk to Camille Terfve about her journey to becoming a ...
Jacqueline Murphy - January 30, 2023 Battery insights & IP trends - new special report We are pleased to announce the launch of our latest special report Battery insights & IP ...
Eleanor Maciver - January 24, 2023 Meet the team: Eleanor Maciver, Partner and Patent Attorney in the Chemistry team, Cambridge As part of our 'meet the team' series, we talk to Eleanor Maciver about her journey to becoming a ...
Lauren Woolley - January 23, 2023 Veganuary: food for thought - ethical considerations when navigating the future food technology landscape Our focus this Veganuary has been on the technology leading the way in this sector, and in ...
Katie Dale - January 21, 2023 CAR Treg cell therapy - to autoimmunity and beyond A new wave of cell therapy is hitting the clinics for treating various autoimmune diseases, by ...
Christopher Casley - January 20, 2023 Meet the team: Christopher Casley, Partner and Patent Attorney in the Life Sciences team, Bristol As part of our 'meet the team' series, we talk to Christopher Casley about why he enjoys life as a ...
Jack Davies - January 20, 2023 Quantum sensors in space: measuring a warming world with cold atoms Space-borne sensors serve a variety of purposes that are all but essential to our daily lives, from ...
Amelia Jones - January 20, 2023 Synthetic Biology - creating innovative solutions to tackle climate change Over the past few decades, awareness of the impact that humans are having on the planet has grown ...
Rebecca Anderson-Smith - January 19, 2023 Veganuary: vegan branding – more than meats the eye The Veganuary challenge is in full swing, at Mewburn Ellis, and across the UK more generally. But ...
Richard Clegg - January 18, 2023 Opting out from the UPC – when to opt-out a pending European patent application From 1 March 2023, when the Unified Patent Court (UPC) sunrise period starts, it will become ...
Lauren Woolley - January 17, 2023 Veganuary: horizons in next-generation plant-based meat analogues Here at Mewburn Ellis, we have been thinking about the future of food for some time. Since 2019, we ...
Sam Bailey - January 16, 2023 Battery innovation - an enabling technology for the reduction of greenhouse emissions From both sides of the research community, companies and academics are working to not only invent ...
Louise Atkins - January 10, 2023 Veganuary: Culturing an appetite; advances in 3D bioprinting Throughout Veganuary, we are looking at the technologies that are taking us beyond animal ...
Jacqueline Murphy - January 9, 2023 Operating in the circular economy: From idea to Business – in person event, Oxford UK, 22 March 2023 We are delighted to be partnering with Oxfordshire Greentech to present an exciting new in person ...
Andy King - January 9, 2023 Form TM7 & TM7A — discrepancies between threatened and actual opponents at the UKIPO Publication of a UK trade mark application, following examination and acceptance by the UK IPO, ...
Angela Nolan - January 4, 2023 Mewburn's The Christie Challenge raises over £30,000! Over the course of September 2021 to September 2022, Mewburn Ellis participated in The Christie ...
Lauren Woolley - January 4, 2023 Mewburn Ellis is proud to be participating in Veganuary At Mewburn Ellis, we have been thinking about the future of food for some time. So have the ...
Alice Jefferies - December 23, 2022 A world-first approval for off-the-shelf cell therapy We are delighted to learn that this week the European Commission granted the world’s first approval ...
Nick Sutcliffe - December 20, 2022 mRNA cancer vaccine shows efficacy in clinical trial Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...
Chris Denison - December 16, 2022 Podcast with Jevan Nagarajah: Cheese without cows Jevan Nagarajah, Co-Founder and CEO of Better Dairy, joins Forward Editor Charles Orton-Jones to ...
Andrew Fearnside - December 15, 2022 The state of quantum Quantum chips are sparking into life. But what is this hardware going to be used for?
Andrew Fearnside - December 15, 2022 Quantum and the law Mewburn Ellis speaks to Kaniah Konkoly-Thege, Chief Legal Officer and Head of Government Relations ...
Joseph Newcombe - December 8, 2022 Joe Newcombe in PharmaTimes — Reality checked In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks at how COP27 ...
Rob Walker - December 5, 2022 Repurpose our rigs! Platforms for climate tech 2022 saw the end of one of the UK’s largest, and possibly most bizarre, public art exhibitions – an ...
Rebecca Anderson-Smith - December 2, 2022 Pharma trade marks: 2022 case law round up As we enter December, and the year draws to a close, many trade mark practitioners and brand owners ...
Joe McAlary - December 2, 2022 Parallel imports of repackaged pharmaceutical products - clarification from recent CJEU rulings Recent case law of the Court of Justice of the European Union (CJEU) has clarified how the ...
Eliot Ward - December 1, 2022 Welcome to the market, FMT On Wednesday 30 November 2022, the U.S. Food and Drug Administration (FDA) authorised the first ...
Thomas Driver - December 1, 2022 What is Synthetic Biology and why should you care? The term Synthetic Biology, or SynBio, has been used for a while; the meaning of the term seems to ...
Alex Galbraith - December 1, 2022 Antibody therapy for pets – following the human lead Over recent decades monoclonal antibody (mAb) therapy has developed from a standing start to become ...
Jack Davies - November 30, 2022 David Deutsch – making more sense than common sense “Our best theories are not only truer than common sense, they make more sense than common sense.” — ...
Jacqueline Murphy - November 29, 2022 Patent Litigation Trends in England & Wales - new report We are delighted to release our latest report Patent Litigation Trends in England and Wales.
Joseph Newcombe - November 25, 2022 Joe Newcombe in PharmaTimes — We are the robots In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks his experience at ...
David Brooks - November 24, 2022 Graphene: the commercial disrupter Graphene has generated a tremendous amount of excitement since it was first isolated at the ...
Jonathan Wills - November 23, 2022 Opposition and examination oral proceedings by videoconference (ViCo) now as standard In response to the significant travel restrictions that were in place across Europe during the ...
Jacqueline Murphy - November 21, 2022 Pharma Trade Marks: Exhaustion and Parallel Trade in the UK - Special Report 2022 We are excited to announce the release of our latest special report Pharma Trade Marks: Exhaustion ...
Thomas Wolter - November 21, 2022 Plausibility and Inventive Step at the EPO - Watch G2/21 live on Thursday 24 November On Thursday 24 November 2022, the Enlarged Board of Appeal (EBA) will hear the parties in case ...
Adam Gregory - November 18, 2022 Coming soon to a plate near you? US Food and Drug Administration issue first step towards approval for cell-based meat For over a decade, the promise of cultivated meat, grown using cell-culture techniques ex vivo and ...
Julie Carlisle - November 16, 2022 European validation strategies for pharmaceutical patents – an update In January 2021, we published our Special Report on EP validation strategies for pharmaceutical ...
Simon Kiddle - November 16, 2022 Positive feedback on oral proceedings in oppositions carried out by videoconference In September, the EPO commissioned a survey about their opposition procedure, in particular asking ...
Edward Couchman - November 11, 2022 Enablement Requirements for Antibody Claims to be Reviewed by US Supreme Court In a development which will be of interest to biotech companies, particularly those working in the ...
Frances Salisbury - November 9, 2022 Gender bias in patent prosecution Fran Salisbury spoke to The Patent Lawyer Magazine about gender bias in patent prosecution. This ...
Katherine Green - November 7, 2022 Eight days – the longest ever opposition hearing at the EPO? The EPO Opposition Division just issued its decision on European Patent 2 188 302 following an ...
Rob Walker - November 4, 2022 Ocean-based carbon dioxide removal is making a splash COP27 commences on 6th November 2022 and one of the key items on the agenda will be the rules ...
Matthew Barton - November 1, 2022 Vets: who’s taking care of the animal caregivers? Our pets are members of the family, and we would do everything we can to make sure they stay fit ...
Paul Dunne - November 1, 2022 Meet the team: Paul Dunne, Partner and Patent Attorney in the Chemistry team, Bristol As part of our 'meet the team' series, we talk to Paul Dunne about his journey to becoming a patent ...
Darena Slavova - November 1, 2022 EPO introduces top-up searches for earlier national rights On 1 September 2022, the EPO introduced an extra “quality check” prior to granting a European ...
Jacqueline Murphy - October 25, 2022 Top Tier in Chambers & Partners 2023 legal guide We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2023 legal ...
Jacqueline Murphy - October 25, 2022 Graphene: patenting a wonder material Our Special Report Graphene: patenting a wonder material examines graphene-related patent ...
Darena Slavova - October 20, 2022 On track for net-zero railway: Hitachi’s Blues Train In 1825 George Stephenson’s Locomotion took 450 people 25 miles from Darlington to Stockton at 15 ...
Robert Andrews - October 20, 2022 Mewburn Ellis Partner with the General Counsel for Diversity & Inclusion We're Proud to Partner with the General Counsel for Diversity & Inclusion (GCD&I) GCD&I ...
James Leach - October 19, 2022 AI at the UKIPO – a more patent friendly approach? The UKIPO recently issued new guidance relating to examining patent applications relating to ...
Camille Terfve - October 17, 2022 Bioinformatics at the UK IPO – what does the new Guidance mean for applicants? As recently publicised, the UK IPO recently issued new guidance relating to examining patent ...
Fynn McLennan - October 17, 2022 Picky and potent: bioorthogonal chemistry in therapy There exist chemical moieties that are essentially invisible to the machinery in the mammalian ...
Jacqueline Murphy - October 14, 2022 Mewburn Ellis: top tier firm Legal 500 2023 We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...
Maria Hall - October 14, 2022 Robert Watson elected President of FICPI’s Study and Work Committee Partner Robert Watson was elected President of FICPI’s Study and Work Committee (Commission d'Etude ...
Joseph Newcombe - October 11, 2022 Joe Newcombe in PharmaTimes — biohazard In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks out to pharma’s ...
Jacqueline Murphy - October 7, 2022 WIPR Diversity Champions & Trailblazers 2022 Congratulations to Robert Andrews and Rebecca Campbell on being recognised as a World Intellectual ...
Jacqueline Murphy - October 5, 2022 Congratulations to our Rising Stars 2022 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Rachel Oxley - October 5, 2022 AI-enabled sensor provides early warning for postpartum haemorrhage Australian start-up Baymatob combines an array of sensors with artificial intelligence to identify ...
Andrew Pitts - October 4, 2022 A patent attorney, a dog and meaning in the job 4 October 2022 is World Animal Day and we can reflect on how the strong bond with our canine ...
Jack Davies - September 27, 2022 Post quantum cryptography – The Final Frontier We have previously reported on the ongoing search by the National Institute of Standards and ...
James Leach - September 26, 2022 Obtaining patent protection for software inventions can be challenging - but we can help New developments in software are continuing to change the world we live in at a rapid pace. Patent ...
Matthew Naylor - September 23, 2022 UPC: Rules of Procedure finalised and in force The Unitary Patent Court now has a revised set of Rules of Procedure. These came into force on 1 ...
Eliot Ward - September 22, 2022 Mewburn Ellis launch Validation Costs Estimator Tool We are pleased to launch our new Validation Costs Estimator Tool. We know that it can be ...
Emma Kennaugh-Gallacher - September 21, 2022 Non-Fungible Tokens as legal property? The world of cryptocurrency is a fast-moving and complex one. Cryptocurrencies such as Bitcoin have ...
Maria Hall - September 20, 2022 Mewburn Ellis leads UK IP sector with a silver medal from EcoVadis Recognition comes as firm launches its in-depth Sustainability Report examining progress to date ...
Matthew Smith - September 13, 2022 Supercrystals A new process allows for the creation of conductive nanocrystals, offering an extraordinarily wide ...
Eliot Ward - September 12, 2022 Regulatory challenges for microbiome therapeutics in the EU and beyond – focus on FMT One of the oldest known microbiome-based therapeutics, faecal microbiota transplantation, is again ...
Karolina Fryzlewicz - August 25, 2022 Pattern trade marks: cross-stitch your way to trade mark registration success We live in a world filled with patterns. The natural world reveals to us many patterned ...
Rob Walker - August 22, 2022 The long road to safer micro-mobility June 2022 marked the first anniversary of the introduction of e-scooters in London as part of the ...
Charlotte Lynch - August 16, 2022 Standards, SEPs, and FRAND agreements - an overview The terms “standards,” “SEPs,” and “FRAND agreements,” are increasingly being mentioned in the ...
James Leach - August 12, 2022 The firepower of Cloud Native thinking Taylor Dolezal of the Cloud Native Computing Foundation explains why the tech industry reveres this ...
Kate O'Rourke - August 11, 2022 Consequences of Brexit on trademarks and designs Just over six years ago, the United Kingdom voted to exit the European Union. With most of the ...
Richard Johnson - August 8, 2022 IP as an enabler for AI: UK government shows its hand The recently published response of the UK government to a consultation on the interface between ...
Charlotte Lynch - August 8, 2022 The FemTech revolution: providing much-needed menopause care High quality menopause care has the potential to significantly improve women’s lives. Fortunately, ...
Emily Hayes - August 5, 2022 We perform significantly better than the EPO average at oppositions We really are experts when it comes to opposing patents and our enviable success rate speaks for ...
Robert Andrews - August 3, 2022 So you want to be a STEMinist The gender imbalance in science and technology is startling. A bold group of pioneers is showing ...
Eleanor Maciver - August 3, 2022 Alternative proteins: you can’t magic anything out of thin air – or can you? It’s hard to miss the scale of investor and consumer appetite for sustainable, future foods. Future ...
Joseph Newcombe - August 1, 2022 Joe Newcombe in PharmaTimes — chemical reaction In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks out to pharma’s ...
Katie Dale - July 28, 2022 Bugs helping drugs beat cancer – harnessing the microbiome for immunotherapy In recent years the field of cancer immunotherapy has exploded in popularity, and now a new branch ...
Katherine Green - July 28, 2022 Most opposed patents of 2021 When we reviewed our list of the most opposed European patents of 2021, we found that the patent at ...
Adam Gregory - July 22, 2022 Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021 2021 was a year of unprecedented success for the biotech and pharmaceutical industries, with the ...
Sam Bailey - July 20, 2022 Electrolytes: the challenge for new-age batteries Most people have heard some version of a horror story about a laptop spontaneously catching fire or ...
Eliot Ward - July 19, 2022 Unitary Patent Package - an overview In this Forward: On Demand vlog, Eliot Ward gives us an overview of the Unitary Patent Package, ...
Callum Anderson - July 8, 2022 MRI-Guided Therapy Magnetic resonance imaging (MRI) scanners use strong magnetic fields and radio waves to produce ...
Eliot Ward - July 7, 2022 Breakthrough: super fast DNA tests A rapid bedside genetic test can screen newborn babies for a genetic variant which makes them ...
Fynn McLennan - July 5, 2022 Bacteria: a surface level understanding Surfaces pose a unique challenge in the on-going war against pathogenic bacteria. Bacteria may ...
Jacqueline Murphy - July 4, 2022 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Thomas Lonsdale - June 30, 2022 High hopes for hydrogen electrolysers: EPO report looks to the future of green hydrogen production Hydrogen is often seen as the “fuel of the future” due to its high energy density, its abundance ...
Robert Andrews - June 28, 2022 Mewburn Ellis announces firmwide menopause policy We are delighted to have launched a firmwide menopause policy to encourage discussion around, and ...
Thomas Wolter - June 27, 2022 EPO presses pause on proceedings that depend on the plausibility referral to the EBA Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Andrew Mears - June 23, 2022 Robotic-assisted surgery: from fiction to reality and beyond It’s a notable feature of (my favourite) Sci-Fi movies, that they tend to include some sort of ...
Jacqueline Murphy - June 23, 2022 Mewburn Ellis win MIP UK Patent Prosecution Firm of the Year! We are delighted to have been named UK Firm of the Year for Patent Prosecution at the Managing IP ...
Julie Carlisle - June 22, 2022 The surprising world of canine oncology Dog cancer specialist Dr Clare Knottenbelt reveals the insights derived from studying and treating ...
Emma Kennaugh-Gallacher - June 21, 2022 The Intellectual Property Enterprise Court – renovation, or a new coat of paint? Comments on the current functioning, and the future, of the IPEC.
Jacqueline Murphy - June 20, 2022 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022 We are delighted to once again be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2022.
Maria Hall - June 16, 2022 Mewburn Ellis advises creators of Goodwood 2022 record breaker IP firm advises the company behind the Spéirling electric hypercar which has just beaten the ...